{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:17:48Z","timestamp":1783041468215,"version":"3.54.6"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2021YFC2301503"],"award-info":[{"award-number":["2021YFC2301503"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.tube.2026.102771","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:49:59Z","timestamp":1777333799000},"page":"102771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A fusion protein LT25 containing Rv2660c failed to provide protection against Mycobacterium bovis infection due to limited humoral immune responses"],"prefix":"10.1016","volume":"159","author":[{"given":"Yuqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianli","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8422-4594","authenticated-orcid":false,"given":"Bingdong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tube.2026.102771_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/zph.12242","article-title":"Molecular epidemiology of Mycobacterium bovis in humans and cattle","volume":"63","author":"El-Sayed","year":"2016","journal-title":"Zoonoses Public Health"},{"issue":"1","key":"10.1016\/j.tube.2026.102771_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00100-19","article-title":"Tuberculosis vaccine development: progress in clinical evaluation","volume":"33","author":"Sable","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tube.2026.102771_bib3","series-title":"Global tuberculosis report 2025","year":"2025"},{"issue":"1","key":"10.1016\/j.tube.2026.102771_bib4","volume":"2","author":"Tran","year":"2014","journal-title":"BCG Vaccines Microbiol Spectr"},{"issue":"6","key":"10.1016\/j.tube.2026.102771_bib5","first-page":"461","article-title":"[Preventive vaccination against tuberculosis: BCG]","volume":"31","author":"LaGrange","year":"1984","journal-title":"Ann Pediatr (Paris)"},{"issue":"8986","key":"10.1016\/j.tube.2026.102771_bib6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"9517","key":"10.1016\/j.tube.2026.102771_bib7","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2026.102771_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2017.00407","article-title":"Immune responses to bacillus calmette-gu\u00e9rin vaccination: why do they fail to protect against mycobacterium tuberculosis?","volume":"8","author":"Moliva","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.tube.2026.102771_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun"},{"issue":"5419","key":"10.1016\/j.tube.2026.102771_bib10","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"issue":"Pt 11","key":"10.1016\/j.tube.2026.102771_bib11","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1099\/13500872-142-11-3135","article-title":"Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis","volume":"142","author":"Philipp","year":"1996","journal-title":"Microbiology (Read)"},{"key":"10.1016\/j.tube.2026.102771_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.712480","article-title":"Mycobacterium tuberculosis-specific T cell functional, memory, and activation profiles in QuantiFERON-Reverters are consistent with controlled infection","volume":"12","author":"Mpande","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.tube.2026.102771_bib13","article-title":"Tuberculosis vaccines and T cell immune memory","volume":"12","author":"Li","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tube.2026.102771_bib14","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.3389\/fimmu.2019.02089","article-title":"Immunogenicity and safety of the M72\/AS01(E) candidate vaccine against tuberculosis: a meta-analysis","volume":"10","author":"Ji","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.tube.2026.102771_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S2213-2600(20)30319-2","article-title":"Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"9","author":"Day","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.tube.2026.102771_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jmii.2014.03.005","article-title":"Recombinant tuberculosis vaccine AEC\/BC02 induces antigen-specific cellular responses in mice and protects Guinea pigs in a model of latent infection","volume":"48","author":"Lu","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"10.1016\/j.tube.2026.102771_bib17","article-title":"Safety and immunogenicity of the GamTBvac, the recombinant subunit tuberculosis vaccine candidate: a phase II, multi-center, double-blind, randomized, placebo-controlled study","volume":"8","author":"Tkachuk","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"10.1016\/j.tube.2026.102771_bib18","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.4049\/jimmunol.2000563","article-title":"Immunization with mycobacterium tuberculosis-specific antigens bypasses T cell differentiation from prior bacillus calmette-gu\u00e9rin vaccination and improves protection in mice","volume":"205","author":"Aagaard","year":"2020","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.tube.2026.102771_bib19","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1038\/s41467-021-26934-0","article-title":"A mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with bacillus calmette-gu\u00e9rin","volume":"12","author":"Woodworth","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.tube.2026.102771_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijid.2020.04.059","article-title":"Ultrasensitive enzyme-linked immunosorbent assay for the detection of MPT64 secretory antigen to evaluate Mycobacterium tuberculosis viability in sputum","volume":"96","author":"Sakashita","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"10\u201311","key":"10.1016\/j.tube.2026.102771_bib21","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.micinf.2009.05.008","article-title":"Novel recombinant RD2- and RD11-encoded Mycobacterium tuberculosis antigens are potential candidates for diagnosis of tuberculosis infections in BCG-vaccinated individuals","volume":"11","author":"Chen","year":"2009","journal-title":"Microb Infect"},{"issue":"3","key":"10.1016\/j.tube.2026.102771_bib22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"Betts","year":"2002","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.tube.2026.102771_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.tube.2026.102771_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jinf.2015.07.011","article-title":"Identification of a novel immunodominant antigen Rv2645 from RD13 with potential as a cell-mediated immunity-based TB diagnostic agent","volume":"71","author":"Luo","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.tube.2026.102771_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1450124","article-title":"The combination of Mycobacterium tuberculosis fusion proteins LT33 and LT28 induced strong protective immunity in mice","volume":"15","author":"He","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2026.102771_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2024.1446930","article-title":"Genomic comparison between Mycobacterium bovis and Mycobacterium microti and in silico analysis of peptide-based biomarkers for serodiagnosis","volume":"11","author":"Moens","year":"2024","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.tube.2026.102771_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.tube.2026.102771_bib28","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.175.4.1111","article-title":"Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages","volume":"175","author":"Chan","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2026.102771_bib29","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.3389\/fimmu.2019.02350","article-title":"IL-2 restores T-Cell dysfunction induced by persistent Mycobacterium tuberculosis antigen stimulation","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.tube.2026.102771_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jcyt.2017.03.067","article-title":"Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion","volume":"19","author":"Kaartinen","year":"2017","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.tube.2026.102771_bib31","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1172\/JCI67008","article-title":"PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells","volume":"123","author":"West","year":"2013","journal-title":"J Clin Investig"},{"key":"10.1016\/j.tube.2026.102771_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.08.027","article-title":"Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines","author":"Vidal","year":"2025","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.tube.2026.102771_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cell.2016.09.041","article-title":"To be or not be a (Functional) antibody against TB","volume":"167","author":"Casadevall","year":"2016","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.tube.2026.102771_bib34","doi-asserted-by":"crossref","first-page":"15688","DOI":"10.1073\/pnas.95.26.15688","article-title":"A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival","volume":"95","author":"Teitelbaum","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.tube.2026.102771_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-1759(87)90187-6","article-title":"Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay","volume":"100","author":"Beatty","year":"1987","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.tube.2026.102771_bib36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2567.2004.01809.x","article-title":"Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs","volume":"111","author":"Williams","year":"2004","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.tube.2026.102771_bib37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41467-021-20930-0","article-title":"Human antibodies targeting a mycobacterium transporter protein mediate protection against tuberculosis","volume":"12","author":"Watson","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.tube.2026.102771_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41541-023-00735-6","article-title":"Author correction: an anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis","volume":"8","author":"Krishnananthasivam","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"6","key":"10.1016\/j.tube.2026.102771_bib39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41591-019-0441-3","article-title":"IFN-\u03b3-independent immune markers of Mycobacterium tuberculosis exposure","volume":"25","author":"Lu","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2026.102771_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.smim.2018.05.003","article-title":"Antibody glycosylation in inflammation, disease and vaccination","volume":"39","author":"Alter","year":"2018","journal-title":"Semin Immunol"},{"issue":"9","key":"10.1016\/j.tube.2026.102771_bib41","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.20151267","article-title":"The role of Fc-Fc\u03b3R interactions in IgG-mediated microbial neutralization","volume":"212","author":"Bournazos","year":"2015","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.tube.2026.102771_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.tube.2026.102771_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.142.1.1","article-title":"Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival","volume":"142","author":"Armstrong","year":"1975","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.tube.2026.102771_bib44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.191.2.287","article-title":"Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages","volume":"191","author":"Malik","year":"2000","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.tube.2026.102771_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1078\/0171-9335-00131","article-title":"Mycobacterial surface moieties are released from infected macrophages by a constitutive exocytic event","volume":"80","author":"Beatty","year":"2001","journal-title":"Eur J Cell Biol"},{"issue":"11","key":"10.1016\/j.tube.2026.102771_bib46","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.15252\/emmm.201606330","article-title":"Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"7","key":"10.1016\/j.tube.2026.102771_bib47","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41423-022-00861-6","article-title":"Role of antibodies in vaccine-mediated protection against tuberculosis","volume":"19","author":"Dieli","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.tube.2026.102771_bib48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.tube.2026.102771_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-med-121217-094234","article-title":"Structure-based vaccine antigen design","volume":"70","author":"Graham","year":"2019","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.tube.2026.102771_bib50","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41467-022-28931-3","article-title":"Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins","volume":"13","author":"Hsieh","year":"2022","journal-title":"Nat Commun"},{"issue":"35","key":"10.1016\/j.tube.2026.102771_bib51","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.tube.2026.102771_bib52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1128\/JVI.74.2.627-643.2000","article-title":"A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure","volume":"74","author":"Binley","year":"2000","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.tube.2026.102771_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathog"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979226000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979226000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:41:49Z","timestamp":1783039309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979226000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":53,"alternative-id":["S1472979226000417"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2026.102771","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A fusion protein LT25 containing Rv2660c failed to provide protection against Mycobacterium bovis infection due to limited humoral immune responses","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2026.102771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102771"}}